Emil Kakkis, Md, Phd

Emil Kakkis, MD, PhD

EveryLife Foundation for Rare Diseases

Emil Kakkis, M.D., Ph.D. - Developing Treatments for Rare Diseases

Sanford Burnham Prebys

Emil Kakkis, MD, PhD, EveryLife Foundation

EveryLife Foundation for Rare Diseases

Emil Kakkis, MD, PhD | The Challenges of Managing Heterogeneity in Rare Diseases

EveryLife Foundation for Rare Diseases

Developing Novel Treatments for Rare Disorders: A Look at MPS I with Dr. Emil Kakkis

WCG

Emil Kakkis - keynote lecture: Translating rare disease research into medicine

Wellcome Connecting Science Learning and Training

Emil Kakkis | 2022 FAST Summit on Angelman Syndrome

FAST

Emil Kakkis, MD, PhD - Nov. 13, 2014 RDLA Caucus Briefing

EveryLife Foundation for Rare Diseases

Emil Kakkis M.D., Ph.D. PKU presentation at Rare Disease Workshop 3

KakkisEveryLife

Emil Kakkis, M.D., Ph.D. opening presentation at Rare Disease Workshop 3

KakkisEveryLife

Emil Kakkis, M.D., Ph.D. final presentation at Rare Disease Workshop 3

KakkisEveryLife

How A Doctor Helped A Young Patient With Fatal Disorder Defy Odds

Wait, How Do You Spell That: A Rare Disease Podcast - Dr. Emil Kakkis, Founder of Ultragenyx

Emil Kakkis, M.D., Ph.D. Urinary GAG presentation at Rare Disease Workshop 3

KakkisEveryLife

Time for an Ultra-Orphan Drug Act by Dr. Emil Kakkis

Cure GM1 Foundation

Emil Kakkis Welcome to Rare Disease Workshop 3

KakkisEveryLife

Translational Medicine Symposium 2013: Dr. Emil Kakkis, 3 of 4

Albert Einstein College of Medicine

Faster Rare Disease Progress is Within our Reach with Dr. Emil Kakkis and Mary Woolley

ResearchAmerica

2019 FAST Science Summit on Angelman Syndrome - Keynote, Dr. Emil Kakkis, Ultragenyx Pharmaceutical

FAST

FDA Approval of Crysvita® for X-linked Hypophosphatemia (XLH)

HPR